{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T16:03:19Z","timestamp":1785168199210,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.cyto.2025.156894","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T13:32:52Z","timestamp":1741095172000},"page":"156894","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The restoration of immunity characterized by the recovery of myeloid dendritic cells represent a favorable response to methylprednisolone therapy for HBV-ACLF patients: A prospective cohort study"],"prefix":"10.1016","volume":"189","author":[{"given":"Lin","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ping","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Chun","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Wei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Hua","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.cyto.2025.156894_bb0005","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1136\/gutjnl-2017-314641","article-title":"Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure","volume":"67","author":"Wu","year":"2018","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.cyto.2025.156894_bb0010","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrgastro.2015.219","article-title":"Acute-on-chronic liver failure: terminology, mechanisms and management","volume":"13","author":"Sarin","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cyto.2025.156894_bb0015","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/gutjnl-2020-323395","article-title":"PBMC transcriptomics identifies immune-metabolism disorder during the development of HBV-ACLF","volume":"71","author":"Li","year":"2022","journal-title":"Gut"},{"issue":"22","key":"10.1016\/j.cyto.2025.156894_bb0020","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1056\/NEJMra1914900","article-title":"Acute-on-chronic Liver failure","volume":"382","author":"Arroyo","year":"2020","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.cyto.2025.156894_bb0025","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/hep.21340","article-title":"Favorable effect of adefovir on the number and functionality of myeloid dendritic cells of patients with chronic HBV","volume":"44","author":"van der Molen","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2025.156894_bb0030","first-page":"1027152","article-title":"Systemic inflammation and acute-on-chronic Liver failure: too much, not enough. Can","author":"Laleman","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.cyto.2025.156894_bb0035","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/hep.28740","article-title":"Systemic inflammation in decompensated cirrhosis: characterization and role in acute-on-chronic Liver failure","volume":"64","author":"Claria","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2025.156894_bb0040","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.3389\/fimmu.2018.02948","article-title":"The role of monocytes and macrophages in acute and acute-on-chronic Liver failure","volume":"9","author":"Triantafyllou","year":"2018","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.cyto.2025.156894_bb0045","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/ni.2691","article-title":"Immune surveillance by the liver","volume":"14","author":"Jenne","year":"2013","journal-title":"Nat Immunol"},{"issue":"6","key":"10.1016\/j.cyto.2025.156894_bb0050","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2217\/imt.15.27","article-title":"Immunotherapy in the treatment and prevention of infection in acute-on-chronic liver failure","volume":"7","author":"Bernsmeier","year":"2015","journal-title":"Immunotherapy"},{"issue":"1","key":"10.1016\/j.cyto.2025.156894_bb0055","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1186\/s12916-020-01814-4","article-title":"The efficacy and safety of methylprednisolone in hepatitis B virus-related acute-on-chronic liver failure: a prospective multi-center clinical trial","volume":"18","author":"Jia","year":"2020","journal-title":"BMC Med"},{"issue":"5","key":"10.1016\/j.cyto.2025.156894_bb0060","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/cmi.2011.51","article-title":"Improved survival ratios correlate with myeloid dendritic cell restoration in acute-on-chronic liver failure patients receiving methylprednisolone therapy","volume":"9","author":"Zhao","year":"2012","journal-title":"Cell Mol Immunol"},{"issue":"9959","key":"10.1016\/j.cyto.2025.156894_bb0065","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","article-title":"Hepatitis B virus infection","volume":"384","author":"Tr\u00e9po","year":"2014","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.cyto.2025.156894_bb0070","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s12072-019-09946-3","article-title":"Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update","volume":"13","author":"Sarin","year":"2019","journal-title":"Hepatol Int"},{"issue":"3","key":"10.1016\/j.cyto.2025.156894_bb0075","first-page":"177","article-title":"Artificial Liver group CSoIDCMA, severe Liver D, artificial Liver group CSoHCMA: [diagnostic and treatment guidelines for liver failure (2012 version)]","volume":"21","author":"Liver","year":"2013","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"3","key":"10.1016\/j.cyto.2025.156894_bb0080","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/cmi.2014.95","article-title":"Dissecting the dendritic cell controversy in chronic hepatitis B virus infection","volume":"12","author":"Gehring","year":"2015","journal-title":"Cell Mol Immunol"},{"issue":"3","key":"10.1016\/j.cyto.2025.156894_bb0085","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jhep.2008.05.017","article-title":"Zou Zs Fau - Fu J-L, Fu Jl Fau - Cai L, Cai L Fau - Jin L, Jin L Fau - Liu Y-J, Liu Yj Fau - Wang F-S, Wang FS: severe dendritic cell perturbation is actively involved in the pathogenesis of acute-on-chronic hepatitis B liver failure","volume":"49","author":"Zhang","year":"2008","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.cyto.2025.156894_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085302","article-title":"Functional limitations of plasmacytoid dendritic cells limit type I interferon, T cell responses and virus control in early life","volume":"8","author":"Belnoue","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.cyto.2025.156894_bb0095","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic Liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cyto.2025.156894_bb0100","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/1751-2980.12691","article-title":"Steroid treatment in patients with acute-on-chronic liver failure precipitated by hepatitis B: a 10-year cohort study in a university hospital in East China","volume":"20","author":"Huang","year":"2019","journal-title":"J Dig Dis"},{"issue":"6","key":"10.1016\/j.cyto.2025.156894_bb0105","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.jhep.2012.06.026","article-title":"Gines P Fau - Olson JC, Olson JC Fau - Mookerjee RP, Mookerjee Rp Fau - Moreau R, Moreau R Fau - Garcia-Tsao G, Garcia-Tsao G Fau - Arroyo V, Arroyo V Fau - Kamath PS, Kamath PS: acute-on chronic liver failure","volume":"57","author":"Jalan","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.cyto.2025.156894_bb0110","first-page":"264","article-title":"Th1\/Th2 cytokine balance in patients with severe chronic hepatitis B and its relationship with prognosis","volume":"2","author":"Lin","year":"2009","journal-title":"Chin J Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.cyto.2025.156894_bb0115","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/gutjnl-2016-312670","article-title":"Acute-on-chronic liver failure: an update","volume":"66","author":"Hernaez","year":"2017","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.cyto.2025.156894_bb0120","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.21607","article-title":"The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids","volume":"45","author":"Louvet","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2025.156894_bb0125","doi-asserted-by":"crossref","first-page":"16041","DOI":"10.1038\/nrdp.2016.41","article-title":"Acute-on-chronic liver failure in cirrhosis","volume":"2","author":"Arroyo","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"10.1016\/j.cyto.2025.156894_bb0130","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1128\/JVI.07000-11","article-title":"Restoration of TLR3-activated myeloid dendritic cell activity leads to improved natural killer cell function in chronic hepatitis B virus infection","volume":"86","author":"Tjwa","year":"2012","journal-title":"J Virol"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466625000419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466625000419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T23:26:39Z","timestamp":1741994799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466625000419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":26,"alternative-id":["S1043466625000419"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2025.156894","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The restoration of immunity characterized by the recovery of myeloid dendritic cells represent a favorable response to methylprednisolone therapy for HBV-ACLF patients: A prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2025.156894","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"156894"}}